Is there an advantage to including the nucleoprotein in a rabies glycoprotein subunit vaccine?

Vaccine

Volumn 17, Issue 11-12, 1999, Pages 1549-1557

  Drings, Astrid ^a   Jallet, Corinne ^a   Chambert, Beatrice ^a   Tordo, Noël ^a   Perrin, Pierre ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

Glycoprotein; Lyssavirus; Nucleoprotein; Protection; Rabies; Recombinant; Vaccine

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; NEUTRALIZING ANTIBODY; NUCLEOPROTEIN; RABIES VACCINE; RECOMBINANT PROTEIN; VIRUS ANTIGEN; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIGEN DETECTION; ANTIGENICITY; ARTICLE; BACULOVIRUS; CELLULAR IMMUNITY; FEMALE; IMMUNE RESPONSE; IMMUNOGENICITY; INFECTION PREVENTION; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RABIES; VACCINE PRODUCTION; VIRUS RECOMBINANT;

ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; BACULOVIRIDAE; FEMALE; GENOTYPE; GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; NUCLEOCAPSID; NUCLEOCAPSID PROTEINS; RABIES VACCINES; RABIES VIRUS; RECOMBINANT PROTEINS; SPODOPTERA; VIRAL ENVELOPE PROTEINS;

EID: 0033577314     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00357-0     Document Type: Article

References (39)

1. Meslin F-X, Fishbein D, Matter H. Rationale and prospects for rabies elimination in developing countries. In: Rupprecht C, editor. Lyssaviruses. Springer-Verlag, 1994. p. 1-26.
2. Tordo N, Charlton K, Wandeler A. Rhabdoviruses: Rabies. In: Collier L, Balows A, Sussman M, editors. Microbiology and microbial infections. London: Arnold, 1998. p. 665-692.
3. Bourhy H., Kissi B., Tordo N. Molecular diversity of the Lyssavirus genus. Virology. 194:1993;70-81.
4. Lodmell D., Smith J., Esposito J., Ewalt L. Cross-protection of mice against a global spectrum of rabies virus variants. J Virol. 69:1995;4957-4962.
5. Lafon M., Bourhy H., Sureau P. Immunity against the European bat rabies (Duvenhage) virus induced by rabies vaccines: an experimental study in mice. Vaccine. 6:1988;362-368.
6. Fekadu M., Shaddock J., Sanderlin D., Smith J. Efficacy of rabies vaccines against virus isolated from European house bats (Eptesicus serotinus), classic rabies and rabies-related virus. Vaccine. 6:1988;533-539.
7. Delagneau J.F., Perrin P., Atanasiu P. Structure of the rabies virus: spatial relationships of the proteins G, M1, M2 and N. Ann Virol (Inst Pasteur). 132E:1981;473-493.
8. Wiktor T., Gyorgy E., Schlumberger D., Sokol F., Koprowski H. Antigenic properties of rabies virus components. J Immunol. 110:1973;269-276.
9. Perrin P., Thibodeau L., Sureau P. Rabies immunosomes (sub unit vaccine) structure and immunogenicity. Pre- and post-exposure protection studies. Vaccine. 3:1985;325-332.
10. Celis E., Ou D., Dietzschold B., Koprowski H. Recognition of rabies and rabies-related viruses by T cells derived from human vaccine recipients. J Virol. 62:1988;3128-3134.
11. MacFarlan R., Dietzschold B., Wiktor T., Kiel M., Houghten R., Lerner R., Sutcliffe G., Koprowski H. T cell responses to cleaved rabies virus glycoprotein and to synthetic peptides. J Immunol. 133:1984;2748-2752.
12. Perrin P., Joffret M.-L., Oth D., Leclerc C., Sureau P., Thibodeau L. Interleukin-2 production in vitro: a new approach to the study of rabies vaccine immunogenicity as appraised by testing different glycoprotein presentations. Vaccine. 6:1988;331.
13. Sokol F., Schlumberger D., Wiktor T., Koprowski H. Biochemical and biophysical studies on the nucleocapsid and on the RNA of rabies virus. Virology. 38:1969;651-665.
14. Flamand A., Wiktor T., Koprowski H. Use of hybridoma monoclonal antibodies in the detection of antigenic differences between rabies and rabies-related virus proteins. II. The glycoprotein. J Gen Virol. 48:1980;105.
15. Flamand A., Wiktor T., Koprowski H. Use of hybrydoma monoclonal antibodies in the detection of antigenic difference between rabies and rabies-related virus proteins. I. The nucleocapsid protein. J Gen Virol. 48:1980;97-104.
16. Ertl H., Dietzschold B., Otvos L. T helper epitope of rabies virus nucleoprotein defined by tri and tetrapeptides. Eur J Immunol. 21:1991;1-10.
17. Dietzschold B., Wang H., Rupprecht C., Celis E., Tollis M., Ertl H., Heber-Katz E., Koprowski H. Induction of protective immunity against rabies by immunization with rabies virus ribonucleoprotein. Proc Natl Acad Sci USA. 84:1987;9165-9169.
18. Pastoret P-P, Brochier B, Aguilar-Setien A, Blancou J. Vaccination against rabies. In: Pastoret P-P, Blancou J, Vannier P, Verschueren C, editors. Veterinary Vaccinology. Amsterdam: Elsevier, 1997. p. 616.
19. Prehaud C., Harris R., Fulop V., Koh C.-L., Wong J., Flammand A., Bishop D. Expression, characterization, and purification of a phosphorylated rabies nucleoprotein synthesized in insect cells by baculovirus vectors. Virology. 178:1990;486-497.
20. Tordo N., Bourhy H., Sather S., Ollo R. Structure and expression in baculovirus of the Mokola virus glycoprotein: an efficient recombinant vaccine. Virology. 194:1993;59-69.
21. Fu Z.F., Dietzschold B., Schumacher C.L., Wunner W.H., Ertl H.C.J., Koprowski H. Rabies virus nucleoprotein expressed in and purified from insect cells is efficacious as a vaccine. Proc Natl Acad Sci USA. 88:1991;2001-2005.
22. Perrin P., Tino de Franco M., Jallet C., Fouque F., Morgeaux S., Tordo N., Colle J.-H. The antigen-specific cell-mediated immune response in mice is suppressed by infection with pathogenic lyssaviruses. Res Virol. 147:1996;289-299.
23. Joffret M.L., Zanetti C., Morgeaux S., Leclerc C., Sureau P., Perrin P. Appraisal of rabies vaccine potency by determination of in vitro, specific interleukin-2 production. Biologicals. 19:1991;113-123.
24. Perrin P. Techniques for the preparation of rabies conjugates. In: Meslin F-X, Kaplan M, Koprowski H, editors. Laboratory techniques in rabies. Geneva: WHO, 1996. p. 433-444.
25. Summers M, Smith G. A manual of methods for baculovirus vectors and insect cell culture procedures. Texas Agricultural Exp. Station Bull., 1988, No. 1555.
26. Maniatis T, Fritsch E, Sambrook J. Molecular cloning: a laboratory manual. Cold Spring Harbor, NY, 1982.
27. Bangham A., Standish M., Watkins J. Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol. 13:1965;238-258.
28. Smith P., Krohn G.et al. Measurement of protein using bicinchonic acid. Anal Biochem. 150:1985;76-85.
29. Perrin P., Rollin P., Sureau P. A rapid rabies enzyme immuno-diagnosis (RREID): a useful and simple technique for the routine diagnosis of rabies. J Biol Standard. 14:1986;217-222.
30. Perrin P, Lafon M, Sureau P. Enzyme-linked immunosorbent assay (ELISA) for the determination of the glycoprotein content of rabies vaccines. In: Meslin F-X, Kaplan M, Koprowski H, editors. Laboratory techniques in rabies. Geneva: WHO, 1996. p. 383-387.
31. Smith J., Yager P., Baer G. A rapid reproducible test for determining rabies neutralizing antibody. Bull Wld Hlth Org. 48:1973;535-541.
32. Perrin P., Versmisse P., Delagneau J.F., Lucas G., Rollin P., Sureau P. The influence of the type of immunosorbent on rabies antibody EIA; advantages of purified glycoprotein over whole virus. J Biol Standard. 14:1986;95.
33. Tuchiya K., Matsuura Y., Kawai A., Ishihama A., Ueda S. Characterization of rabies virus glycoprotein expressed by recombinant baculovirus. Virus Res. 25:1992;1-13.
34. Pinto R., Bosh A., Bishop D. Structures associated with the expression of rabies virus stuctural genes in insect cells. Virus Res. 31:1994;139-145.
35. Hooper C., Pierard I., Modelska A., Otvos L., Fu Z., Koprowski H., Dietzschold B. Rabies nucleocapsid as an oral immunogen and immunological enhancer. Proc Natl Acad Sci USA. 91:1994;10908-10912.
36. Astoul E., Lafage M., Lafon M. Rabies superantigen as a Vβ T-dependent adjuvant. J Exp Med. 183:1996;1623-1631.
37. Lodmell D., Sumner J., Esposito J., Bellini W., Ewalt L. Raccoon poxvirus recombinants expressing the rabies virus nucleoprotein protect mice against lethal rabies virus infection. J Virol. 65:1991;3400-3405.
38. Herzog M., Fritzell C., Lafage M., Montano-Hirose J., Scott-Algara D. T and B cell human responses to European bat lyssavirus after post-exposure rabies vaccination. Clin Exp Immunol. 85:1991;224-230.
39. Perrin P., Joffret M.L., Zanetti C., Bourhy H., Gontier C., Fritzell C., Leclerc C., Sureau P. Rabies-specific production of interleukin-2 by peripheral blood lymphocytes from human rabies vaccinees. Vaccine. 9:1991;549-558.